ClinicalTrials.gg
RecruitingNCT04631939Macu'taUpdated May 10, 2023

Metacognitive Training as a Serious Game

An interventional study of Metacognitive training game and Control games in Schizophrenia and Related Disorders, Psychotic Disorders and Delusions, sponsored by Christina Andreou. Recruiting at 2 sites in 2 countries. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2023-05-10.

Sponsored by Christina Andreou · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2023, 2 years 11 months ago, but the record still lists the study as recruiting.
  • Started Jun 2021; still recruiting 5 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The project aims to evaluate the efficacy of a therapeutic video game that incorporates elements from metacognitive training on delusions and jumping-to-conclusions in patients with psychotic disorders.

Read the detailed description

The study is an international, multicenter study and is being conducted in Switzerland (University of Basel) as well as in Germany (University of Lübeck). A total of 36 participants will be included. The estimated duration of the study is 15 months. All participants play a video game from the genre "Third Person Adventure". A character is navigated through a fantasy world using a keyboard and mouse. In the fantasy world, "stations" in the form of glowing gems are sought where players have to solve different tasks.

Participants are randomized to receive either the therapeutic video game with metacognitive training content or another video game with attention and memory tasks ("control intervention"). The control intervention does not include metacognitive tasks. Metacognitive training is an approach for the treatment of psychotic disorders, particularly delusions. The focus of metacognitive training is on thought distortions (so-called "cognitive biases") that are more pronounced in people with psychosis. The control intervention includes easily understandable, playful tasks. The intervention will take 4 appointments within 2 weeks.

02

Conditions studied

  • Schizophrenia and Related Disorders
  • Psychotic Disorders
  • Delusions

Keywords

  • Psychotic disorders
  • Delusions
  • Metacognitive Training
  • Schizophrenia
03

In context

Schizophrenia

3,563 studies on the registry are indexed under Schizophrenia; 491 are open to participants now.

This study's planned enrollment of 36 is below the median of 71 across 2,944 interventional studies indexed under Schizophrenia.

Browse Schizophrenia studies →

Lead sponsor

This is the only study on the registry with Christina Andreou as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • aged between 18 and 40
  • diagnosis of a psychotic disorder and current delusions or a history of delusions

Exclusion criteria

Exclusion Criteria:

  • Language skills insufficient for assessments
  • IQ \< 70
  • Secondary psychotic disorders that are clearly induced by general medical conditions or substance use.
  • Previous participation in meta-cognitive training for psychosis
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    study intervention

    The intervention consists of a puzzle adventure game, in which players have to explore the fantasy world "Macu'ta". The puzzles are based on Metacognitive Training for Psychosis (MCT), an intervention using playful, entertaining exercises to increase awareness of reasoning biases in patients and 'sow the seeds of doubt' through corrective ('aha!') experiences. The tasks will address reasoning biases associated with the emergence and maintenance of delusions.

    Device: Metacognitive training game

  • Sham comparator
    control intervention

    The control intervention consists of a puzzles focused exclusively on dexterity and accuracy.

    Device: Control games

Interventions

  • DeviceMetacognitive training game

    In the fantasy world "Macu'ta", players explore the world by walking around with an avatar in order to find the puzzles and proceed in the game. The intervention consists of 4 different puzzles. Unbeknownst to the player, the first pieces of evidence of each puzzle are often misleading, i.e. indicate the wrong solution, such that hasty decisions are punished. Players receive immediate feedback and are shown the correct response after submitting their solution, as well as explicit cues that educate them on the value of making adequately informed decisions. The order of the puzzles is fixed for each player, but different per session.

  • DeviceControl games

    In the fantasy world "Macu'ta", players explore the world by walking around with an avatar in order to find the puzzles and proceed in the game. The control intervention consists of 4 different puzzle games requiring exclusively dexterity and accuracy (i.e., not including any metacognitive elements). The order of the puzzles is fixed for each player, but different per session.

06

What researchers measure

Primary outcomes

  1. Change of delusion severity

    Item P1 of the Positive and Negative Syndrome Scale (PANSS). Min score = 1, max score = 7, where lower scores indicate better outcome.

    Time frame: Change from pre- to post-intervention (4 weeks)

Secondary outcomes

  1. Change of total PANSS Score

    Total score on the Positive and Negative Syndrome Scale. Lower scores indicate better outcome.

    Time frame: Change from pre- to post-intervention (4 weeks)

  2. Change of delusional conviction

    Total score on the Psychotic Symptom Rating Scales, delusion part (PSYRATS). Lower scores indicate better outcome.

    Time frame: Change from pre- to post-intervention (4 weeks)

  3. Fish Task: change of number of draws to decision

    Number of draws to decision, assessed with the 'Fish task'

    Time frame: Change from pre- to post-intervention (4 weeks)

  4. Fish Task: change of probability threshold to decision

    Probability threshold to decision, assessed with the 'Fish task'

    Time frame: Change from pre- to post-intervention (4 weeks)

07

Study locations

1 of 2 sites recruiting
  • Center for Integrative Psychiatry Lübeck
    Lübeck, Schleswig-Holstein 23538, Germany
    Not yet recruiting
    • Stefan Borgwardt, MD, PhD · Contact
  • University Psychiatric Clinics Basel
    Basel, Basel-Stadt 4055, Switzerland
    Recruiting
    • Renate de Bock, MSc · Contact
08

References and documents

Individual participant data

Plan to share: Yes — All data we will be published on Zenodo under CC0 license.

Supporting information: Study protocol

Time frame: All data will be made openly accessible one year after the study end.

Access criteria: will be determined at a later time

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 10, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04631939
Lead sponsor
Christina Andreou
Responsible party
Christina Andreou (Principal Investigator, University of Basel) — Sponsor-investigator
First posted
Nov 17, 2020
Start date
Jun 1, 2021
Primary completion
Dec 2023 (estimated)
Completion
Dec 2023 (estimated)
Last update
May 10, 2023

Study contacts

Christina Andreou, PD. Dr.
Contact
christina.andreou@unibas.ch
+41 61 325 8157
Renate de Bock, MSc
Contact
renate.debock@unibas.ch
+41 61 325 8157
Christina Andreou, PD Dr.
principal investigator · University of Basel
Stefan Borgwardt, Prof. Dr.
principal investigator · University of Luebeck

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion